Diffuse large B cell (DLBCL) and high grade B cell lymphomas (HGBL) demonstrating MYC translocation with concurrent BCL2 and/or BCL6 rearrangements, colloquially called double and triple hit lymphomas (DHL and THL), have poor clinical outcomes2. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.